scholarly journals Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial

Cancer ◽  
2018 ◽  
Vol 124 (10) ◽  
pp. 2169-2173 ◽  
Author(s):  
Kathryn A. Gold ◽  
Merrill S. Kies ◽  
William N. William ◽  
Faye M. Johnson ◽  
J. Jack Lee ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Phase 2 Clinical Trial

Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9519-9519 ◽  
Author(s):  
Danny Rischin ◽  
Michael Robert Migden ◽  
Anne Chang ◽  
Christine H. Chung ◽  
Lara Dunn ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Primary Analysis

scholarly journals Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

2020 ◽  
Vol 21 (2) ◽  
pp. 294-305 ◽  
Author(s):  
Michael R Migden ◽  
Nikhil I Khushalani ◽  
Anne Lynn S Chang ◽  
Karl D Lewis ◽  
Chrysalyne D Schmults ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Locally Advanced ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Phase

scholarly journals Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up

2020 ◽  
Vol 4 (6) ◽  
pp. s124
Author(s):  
Danny Rischin ◽  
Nikhil Khushalani ◽  
Chryslalyne Schmults ◽  
Alexander Guminski ◽  
Anne Lynn Chang ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cutaneous Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Phase 2 Study

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document